Page last updated: 2024-12-07

ethylene glycolylbis(succinimidyl succinate)

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID123663
SCHEMBL ID141048
MeSH IDM0092170

Synonyms (38)

Synonym
nsc-340009
nsc340009
70539-42-3
ethylene glycol-bis(succinic acid n-hydroxysuccinimide ester), powder
ethylene glycolylbis(succinimidyl succinate)
ethylene glycol-bis(succinic acid n-hydroxysuccinimide ester)
ethylene glycol bis(succinimidyl succinate)
4-o-(2,5-dioxopyrrolidin-1-yl) 1-o-[2-[4-(2,5-dioxopyrrolidin-1-yl)oxy-4-oxobutanoyl]oxyethyl] butanedioate
egnhs
nsc 340009
egbss
butanoic acid, 4-((2,5-dioxo-1-pyrrolidinyl)oxy)-4-oxo-, 1,2-ethanediyl ester
ethylene glycolyl bis(succinimidylsuccinate)
FT-0626299
AKOS015892852
SCHEMBL141048
egs crosslinker (ethylene glycol bis(succinimidyl succinate))
BP-22662
bis(2,5-dioxopyrrolidin-1-yl) o,o'-ethane-1,2-diyl disuccinate ,
ethylene glycol bis(succinic acid n-hydroxysuccinimide ester)
bis(2,5-dioxopyrrolidin-1-yl) o,o'-(ethane-1,2-diyl) disuccinate
bis(2,5-dioxopyrrolidin-1-yl) o,o-ethane-1,2-diyl disuccinate
mfcd00049057
egs crosslinker
ethane-1,2-diyl bis{4-[(2,5-dioxopyrrolidin-1-yl)oxy]-4-oxobutanoate}
DTXSID20990737
ethlene glycol bis(succinimidyl succinate)
bis(2,5-dioxopyrrolidin-1-yl) '-ethane-1,2-diyl disuccinate
ethylene glycolbis(succinimidylsuccinate)
egscrosslinker
C70585
ethylene glycol-bis (succinic acid n-hydroxysuccinimide ester)
CS-0108027
HY-130458
FZX9NM7QE4
ethylene glycol bis(succinic acid n-hydroxy succinimide ester)
di(succinimidyl) 4,4'-[(ethylene)dioxy]bis(4-oxobutanoate)
butanedioic acid, 1,1'-(1,2-ethanediyl) 4,4'-bis(2,5-dioxo-1-pyrrolidinyl) ester
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (43)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (34.88)18.7374
1990's21 (48.84)18.2507
2000's5 (11.63)29.6817
2010's2 (4.65)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.44

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.44 (24.57)
Research Supply Index3.83 (2.92)
Research Growth Index4.27 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.44)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other45 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]